Evidence map›Paper›PMID 36293312›Full record

ArticleInternational journal of molecular sciences2022

Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report.

Gabriele Nieddu, Elena Michelucci, Marilena Formato, Cristina Ciampelli, Gabriele Obino, Giovanni Signore, Nicoletta Di Giorgi, Silvia Rocchiccioli, Antonio Junior Lepedda

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics.Journal of cardiovascular development and disease · 2025
    Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Atherogenic circulating lipoproteins in ischemic stroke.Frontiers in cardiovascular medicine · 2024
    Review
  10. Lipids Metabolism and Cardiometabolic Diseases.International journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gabriele NiedduDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-9268-9436
Elena MichelucciInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0002-1619-401X
Marilena FormatoDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Cristina CiampelliDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Gabriele ObinoDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-3192-755X
Giovanni SignoreDepartment of Biology, Biochemistry Unit, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0067-2240
Nicoletta Di GiorgiInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.
Silvia RocchiccioliInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0003-3831-4200
Antonio Junior LepeddaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-8356-894X
University of Sassari · ITIstituto di Fisiologia Clinica · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carotid atherosclerosis represents a relevant healthcare problem, since unstable plaques are responsible for approximately 15% of neurologic events, namely transient ischemic attack and stroke. Although statins treatment has proven effective in reducing LDL-cholesterol and the onset of acute clinical events, a residual risk may persist suggesting the need for the detection of reliable molecular markers useful for the identification of patients at higher risk regardless of optimal medical therapy. In this regard, several lines of evidence show a relationship among specific biologically active plasma lipids, atherosclerosis, and acute clinical events. We performed a Selected Reaction Monitoring-based High Performance Liquid Chromatography-tandem Mass Spectrometry (SRM-based HPLC-MS/MS) analysis on plasma HDL, LDL, and VLDL fractions purified, by isopycnic salt gradient ultracentrifugation, from twenty-eight patients undergoing carotid endarterectomy, having either a "hard" or a "soft" plaque, with the aim of characterizing the specific lipidomic patterns associated with features of carotid plaque instability. One hundred and thirty lipid species encompassing different lipid (sub)classes were monitored. Supervised multivariate analysis showed that lipids belonging to phosphatidylethanolamine (PE), sphingomyelin (SM), and diacylglycerol (DG) classes mostly contribute to discrimination within each lipoprotein fraction according to the plaque typology. Differential analysis evidenced a significant dysregulation of LDL PE (38:6), SM (32:1), and SM (32:2) between the two groups of patients (adj.

Indexed as

AtherosclerosisHydroxymethylglutaryl-CoA Reductase InhibitorsPlaque, AtheroscleroticBiomarkersCholesterolDiglyceridesHumansLipoproteinsLipoproteins, LDLPhosphatidylethanolaminesPhospholipidsSphingomyelinsTandem Mass SpectrometryBiomarkersCholesterolDiglyceridesHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteinsLipoproteins, LDLPhosphatidylethanolaminesPhospholipidsSphingomyelinscarotid atherosclerosislipoproteinsphosphatidylethanolamineplaque vulnerabilitysphingomyelintargeted lipidomics

Identifiers

PMID36293312
PMCPMC9604033
OpenAlexW4306743360

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.